Pure Global AI
NCT06392633Recruiting

SURGERY VS BOTULINUM TOXIN ON QUALITY OF LIFE IN STROKE PATIENTS: RANDOMIZED TRIAL

SURGERY VS BOTULINUM TOXIN ON QUALITY OF LIFE IN STROKE PATIENTS
Fundación Pública Andaluza para la Investigación Biomédica Andalucía OrientalClinicalTrials.govprocedure
Verified
Study focus
Disease/Condition
Stroke
Drug/Device/Intervention
spastic hand sugery
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Location
Granada, Spain
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2021
End date
Dec 01, 2024
Enrollment
44 participants
Primary outcome

Quality of life by 36-Item Short Form Survey Instrument (SF-36),Quality of life by Newcastle Stroke-Specific Quality of Life Measure

Summary

We present a research project in the form of a controlled clinical trial with the aim of
 analyzing and demonstrating whether the surgical treatment of upper limb spasticity is an
 effective and efficient measure to improve dependence and quality of life perceived by
 patients with sequelae of stroke and therefore, should be included in the therapeutic
 protocols, in which it is not usually contemplated, as a complement or alternative to
 traditional treatment with botulinum toxin, rehabilitation and occupational therapy.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionFamily history of strokeCerebral infarction, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06392633
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06392633 through Pure Global AI's free database. This phase not specified trial is sponsored by Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental and is currently Recruiting. The study focuses on Stroke. Target enrollment is 44 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.